Psychoeducation and Well-Being After Breast Cancer
NCT07284030
Summary
This randomized controlled trial evaluates the effectiveness of a web-based psychoeducation program on psychological well-being and quality of life in breast cancer survivors who completed active treatment at least one year earlier. Seventy-two women will be randomly assigned to either a 6-week online psychoeducation program plus standard care or standard care alone. The intervention consists of weekly 30-45 minute online sessions focusing on coping strategies, psychosocial adjustment, quality of life, and psychological well-being. Primary outcomes include psychological well-being, fear of cancer recurrence, quality of life, and hopelessness, assessed at baseline, post-intervention, and 2-month follow-up.
Eligibility
Inclusion Criteria: * Female breast cancer survivors * Completed active breast cancer treatment (surgery, chemotherapy, radiotherapy) at least 12 months ago * Currently in remission (no evidence of active disease) * Age between 18-65 years * Able to read and write Turkish * Access to computer or smartphone with internet connection * Able to participate in online video sessions via Zoom * Willing to provide informed consent Exclusion Criteria: * Current cancer recurrence or metastatic disease * Active psychiatric disorder requiring treatment * Cognitive impairment that prevents participation in online sessions * Currently receiving active cancer treatment (excluding hormonal therapy) * Participation in another psychosocial intervention study * No internet access or inability to use web-based platforms * Male breast cancer patients * Unable to commit to 6-week program schedule
Conditions5
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07284030